Meda Pharmaceuticals Overview

  • Founded
  • 2001

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 201

Employees
  • Latest Deal Type
  • M&A

  • (Cancelled)
  • Financing Rounds
  • 3

  • Investments
  • 1

Meda Pharmaceuticals General Information

Description

Manufacturer of pharmaceutical products in the United States. The company specializes in the manufacturing of pharmaceutical products for respiratory disease, allergy, gastroenterology, rheumatology and other pharmaceutical medicines.

Contact Information

Formerly Known As
Carter-Wallace (Healthcare Business)
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • 265 Davidson Avenue
  • Suite 300
  • Franklin Township, NJ 08873
  • United States
+1 (732) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Meda Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Meda Pharmaceuticals‘s full profile, request access.

Request a free trial

Meda Pharmaceuticals Patents

Meda Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2677076-C Compositions comprising carisoprodol and methods of use thereof Active 02-Mar-2007 0000000000
CA-2677076-A1 Compositions comprising carisoprodol and methods of use thereof Granted 02-Mar-2007 0000000000
US-8895061-B2 Compositions comprising carisoprodol and methods of use thereof Active 02-Mar-2007 0000000000 00
US-20100189782-A1 Compositions comprising carisoprodol and methods of use thereof Granted 02-Mar-2007 0000000000 00
US-20070020330-A1 Compositions comprising azelastine and methods of use thereof Abandoned 24-Nov-2004 A61K9/0043 00
To view Meda Pharmaceuticals’s complete patent history, request access »

Meda Pharmaceuticals Executive Team (11)

Name Title Board Seat Contact Info
Anthony Vaccarelli Chief Information Officer & Vice President
Dennis Fuge Vice President, Manufacturing
James Fitzpatrick Vice President, Marketing
You’re viewing 3 of 11 executive team members. Get the full list »

Meda Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Meda Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Meda Pharmaceuticals‘s full profile, request access.

Request a free trial

Meda Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 01-May-2001 0000000000 Laboratory Services (Healthcare)
To view Meda Pharmaceuticals’s complete acquisitions history, request access »

Meda Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000000 01-May-2001 000000000000000000 Completed
  • 0000 0000000000000
To view Meda Pharmaceuticals’s complete exits history, request access »